上述研究调查了三十年来三级医院血管高风险患者在现实世界中使用降糖药物的情况，得出了几个新发现。首先，研究发现了大量新诊断的糖尿病患者；然而，患病率随着时间的推移而下降（从OS1的43.8%下降到OS3的27.2%），HbA1c水平也是如此。其次，接受 ...

Polypharmacy is associated with poor clinical outcomes following COVID-19 infection among patients with type 2 diabetes.

Consultant in endocrinology and diabetes Professor Vinod Patel discusses current recommended pharmacological treatment options for the management of type 2 diabetes, including how to initiate SGLT2 ...

SGLT2 inhibitors reduce the risk of kidney failure in patients with Type 2 diabetes and advanced chronic kidney disease, ...

Appropriate use of anti-diabetic medications with proven benefit in reducing CV events in people with T2DM with established CVD or in those at high risk for CVD shall further reduce the burden of ...